#labonchip #diagnostics #remotehealthcare #affordablehealthcare #remotepathology #healthtech #rapiddiagnostics #3dprinting
A team of researchers at Imperial College London, led by Dr. Pantelis Georgiou, is tackling this problem head-on with a project called Lacewing for pathogen detection. Offering results within 20 minutes from a smartphone app synced to a cloud server, Lacewing makes disease testing portable, including SARD-CoV-2-RNA, and automates the tracking of disease progression through geotagging.
It is a sophisticated “lab-on-a-chip” platform that promises to fill the access- and information-gaps in the world of diagnostics by combining molecular biology and state-of-the-art technology. Whereas other diagnostics technology requires large and expensive optical equipment, the electrical sensing method and small size of Lacewing is a true evolution in approach.
The Lacewing platform is a molecular diagnostic test that works by identifying the DNA or RNA of a pathogen within a patient sample. This type of test makes it possible to determine not only if someone is infected with a certain disease (dengue, malaria, tuberculosis, COVID-19, etc.), but to what degree, which provides more insight into the severity of the symptoms.
Read on
Rapid Diagnostics Device Developed Using Figure 4 Standalone | 3D Systems
The Lacewing project out of Imperial College London is a lab-on-a-chip platform for diagnosing and tracking diseases, with key components 3D printed using 3D Systems' Figure 4 and biocompatible-capable materials.
No comments:
Post a Comment